Table 1.
Comorbidities in surviving and deceased patients. Percentage indicated in relation to total group within individual comorbidity.
| Comorbidity | Y/N (number in subcategory) | Survived (% within subcategory) | Died (%) | Univariate P value |
|---|---|---|---|---|
| Obesity | N (766) | 694 (90) | 72 (9.4) | 0.11 |
| Y (216) | 187 (87) | 29 (13) | ||
| Unknown (93) | 93 | 0 | ||
|
| ||||
| Diabetes | N (741) | 690 (93) | 51 (7) | <0.001 |
| Y (334) | 284 (85) | 50 (15) | ||
|
| ||||
| Hypertension | N (820) | 760 (93) | 60 (7) | <0.001 |
| Y (255) | 214 (84) | 41(16) | ||
|
| ||||
| Cardiovascular disease | N (988) | 905 (92) | 83 (8) | <0.01 |
| Y (87) | 69 (79) | 18 (21) | ||
|
| ||||
| COPD | N (1073) | 972 (91) | 101 (9) | >0.5 |
| Y (2) | 2 (100) | 0 (0) | ||
|
| ||||
| Asthma | N (1045) | 946 (91) | 99 (9) | >0.5 |
| Y (30) | 28 (93) | 2 (7) | ||
|
| ||||
| Chronic renal disease | N (1026) | 937 (91) | 89 (9) | <0.01 |
| Y (49) | 37 (76) | 12 (24) | ||
|
| ||||
| Liver disease | N (1071) | 972 (91) | 99 (9) | <0.0 |
| Y (4) | 2 (50) | 2 (50) | ||
|
| ||||
| Malignancy | N(1057) | 962 (91) | 95 (9) | <0.01 |
| Y (18) | 12 (67) | 6 (33) | ||